#527 on the rich list of 14,644 insiders
Neil Kumar
Chief Executive Officer at BridgeBio Pharma. Based in Palo Alto, California.
$439M
in disclosed stock, +$2.5M (+0.58%) today
Live prices, last trade 2:45 PM ET
- Rank
- 527th of 14,644
- Companies held
- 1
- Largest holding
- BBIO, 100.0% of total
- Latest SEC filing
- Nov 16, 2026
What the $439M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| BridgeBio Pharma BBIO Common Stock | Through Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee. | 3,568,447 | $78.46 | $280M | 63.7% | Form 4, Nov 16, 2026 |
| BridgeBio Pharma BBIO Common Stock | Through NK 2026 GRAT | 750,000 | $78.46 | $58.8M | 13.4% | Form 4, Nov 16, 2026 |
| BridgeBio Pharma BBIO Common Stock | Indirectly (see filing footnote) | 505,686 | $78.46 | $39.7M | 9.0% | Form 4, Aug 19, 2026 |
| BridgeBio Pharma BBIO Common Stock | Through Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee. | 495,686 | $78.46 | $38.9M | 8.9% | Form 4, Nov 16, 2026 |
| BridgeBio Pharma BBIO Common Stock | Directly | 278,307 | $78.46 | $21.8M | 5.0% | Form 4, Nov 16, 2026 |
Share counts are the amounts Neil Kumar reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Open-market trades, last 12 months
| Date | Trade | Company | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Sep 17, 2026 | Sold | BBIO | 1,279 | $69.57 | $89K | View |
| Sep 17, 2026 | Sold | BBIO | 8,721 | $69.01 | $602K | View |
| Aug 19, 2026 | Sold | BBIO | 100 | $85.65 | $9K | View |
| Aug 19, 2026 | Sold | BBIO | 1,800 | $84.69 | $152K | View |
| Aug 19, 2026 | Sold | BBIO | 8,100 | $83.86 | $679K | View |
| Aug 18, 2026 | Sold | BBIO | 14,602 | $82.99 | $1.2M | View |
| Aug 18, 2026 | Sold | BBIO | 1,900 | $81.15 | $154K | View |
| Aug 18, 2026 | Sold | BBIO | 17,279 | $82.21 | $1.4M | View |
| Aug 18, 2026 | Sold | BBIO | 1,199 | $83.77 | $100K | View |
| Jun 5, 2026 | Sold | BBIO | 7,147 | $67.20 | $480K | View |
| Jun 5, 2026 | Sold | BBIO | 4,415 | $68.96 | $304K | View |
| Jun 5, 2026 | Sold | BBIO | 4,416 | $68.96 | $305K | View |
| Jun 5, 2026 | Sold | BBIO | 8,437 | $67.88 | $573K | View |
| Jun 5, 2026 | Sold | BBIO | 8,437 | $67.88 | $573K | View |
| Jun 5, 2026 | Sold | BBIO | 7,148 | $67.20 | $480K | View |
| Jun 4, 2026 | Sold | BBIO | 2,200 | $65.72 | $145K | View |
| Jun 4, 2026 | Sold | BBIO | 1,429 | $66.72 | $95K | View |
| Jun 4, 2026 | Sold | BBIO | 15,921 | $67.74 | $1.1M | View |
| Jun 4, 2026 | Sold | BBIO | 450 | $68.27 | $31K | View |
| Jun 4, 2026 | Sold | BBIO | 2,200 | $65.72 | $145K | View |
| Jun 4, 2026 | Sold | BBIO | 1,429 | $66.72 | $95K | View |
| Jun 4, 2026 | Sold | BBIO | 15,921 | $67.74 | $1.1M | View |
| Jun 4, 2026 | Sold | BBIO | 450 | $68.27 | $31K | View |
| May 21, 2026 | Sold | BBIO | 800 | $70.92 | $57K | View |
| May 21, 2026 | Sold | BBIO | 2,256 | $67.57 | $152K | View |
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 524 | Philip H. Knight Insider, NIKE. Beaverton, OR | $441M |
| 525 | Yair Nechmad CEO, Co Founder & Chairman, Nayax | $441M |
| 526 | Yoshiyuki Aikawa Chairman and CEO, SBC Medical Group Holdings. Irvine, CA | $441M |
| 527 | Neil Kumar Chief Executive Officer, BridgeBio Pharma. Palo Alto, CA | $439M |
| 528 | P. Roy Vagelos Director, Regeneron Pharmaceuticals. Tarrytown, NY | $435M |
| 529 | Ira Ehrenpreis Director, Tesla. Starbase, TX | $435M |
| 530 | Jonathan Gray President & COO, Blackstone. New York, NY | $434M |
Other BridgeBio Pharma insiders
All BBIO insiders- Charles J. Homcy$72.2MDirector. #1922 overall
- Frank McCormick$60.2MDirector. #2240 overall
- Thomas Trimarchi$24.6MPresident and CFO. #4443 overall
- Ali J. Satvat$13.3MDirector. #7109 overall
- Maricel Apuli$9.1MChief Accounting Officer. #9459 overall
- Brian C. Stephenson$8.0MCFO and Treasurer. #10012 overall
Questions
How much stock does Neil Kumar own?
Neil Kumar holds $439,228,966 in listed stock based on SEC filings and current prices, mostly BridgeBio Pharma (BBIO). That ranks 527th on the Stock Rich List.
Is this Neil Kumar's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Neil Kumar last buy or sell stock?
The most recent open-market trade on file is a sale of 1,279 BBIO shares on Sep 17, 2026 at $69.57.